RESUMEN
Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.
Asunto(s)
Asma/fisiopatología , Hipersensibilidad/fisiopatología , Neumonía/fisiopatología , Receptores de Quimiocina/fisiología , Animales , Asma/inmunología , Asma/metabolismo , Citocinas/metabolismo , Hipersensibilidad/inmunología , Hipersensibilidad/metabolismo , Inmunoglobulina E/biosíntesis , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Neumonía/inmunología , Neumonía/metabolismo , Receptores CCR6 , Receptores de Quimiocina/genética , Receptores de Quimiocina/metabolismo , Células Th2/inmunología , Células Th2/metabolismoRESUMEN
ADP plays a critical role in modulating thrombosis and hemostasis. ADP initiates platelet aggregation by simultaneous activation of two G protein-coupled receptors, P2Y1 and P2Y12. Activation of P2Y1 activates phospholipase C and triggers shape change, while P2Y12 couples to Gi to reduce adenylyl cyclase activity. P2Y12 has been shown to be the target of the thienopyridine drugs, ticlopidine and clopidogrel. Recently, we cloned a human orphan receptor, SP1999, highly expressed in brain and platelets, which responded to ADP and had a pharmacological profile similar to that of P2Y12. To determine whether SP1999 is P2Y12, we generated SP1999-null mice. These mice appear normal, but they exhibit highly prolonged bleeding times, and their platelets aggregate poorly in responses to ADP and display a reduced sensitivity to thrombin and collagen. These platelets retain normal shape change and calcium flux in response to ADP but fail to inhibit adenylyl cyclase. In addition, oral clopidogrel does not inhibit aggregation responses to ADP in these mice. These results demonstrate that SP1999 is indeed the elusive receptor, P2Y12. Identification of the target receptor of the thienopyridine drugs affords us a better understanding of platelet function and provides tools that may lead to the discovery of more effective antithrombotic therapies.
Asunto(s)
Plaquetas/efectos de los fármacos , Fibrinolíticos/farmacología , Proteínas de la Membrana , Antagonistas del Receptor Purinérgico P2 , Ticlopidina/farmacología , Adenosina Difosfato/farmacología , Adenilil Ciclasas/metabolismo , Animales , Tiempo de Sangría , Coagulación Sanguínea , Plaquetas/metabolismo , Células Cultivadas , Clopidogrel , Marcación de Gen , Cinética , Ratones , Ratones Noqueados , Agregación Plaquetaria/efectos de los fármacos , Receptores Purinérgicos P2/genética , Receptores Purinérgicos P2Y12 , Ticlopidina/análogos & derivadosRESUMEN
Fractalkine (CX(3)CL1) is the first described chemokine that can exist either as a soluble protein or as a membrane-bound molecule. Both forms of fractalkine can mediate adhesion of cells expressing its receptor, CX(3)CR1. This activity, together with its expression on endothelial cells, suggests that fractalkine might mediate adhesion of leukocytes to the endothelium during inflammation. Fractalkine is also highly expressed in neurons, and its receptor, CX(3)CR1, is expressed on glial cells. To determine the biologic role of fractalkine, we used targeted gene disruption to generate fractalkine-deficient mice. These mice did not exhibit overt behavioral abnormalities, and histologic analysis of their brains did not reveal any gross changes compared to wild-type mice. In addition, these mice had normal hematologic profiles except for a decrease in the number of blood leukocytes expressing the cell surface marker F4/80. The cellular composition of their lymph nodes did not differ significantly from that of wild-type mice. Similarly, the responses of fractalkine(-/-) mice to a variety of inflammatory stimuli were indistinguishable from those of wild-type mice.
Asunto(s)
Quimiocinas CX3C , Quimiocinas CXC/inmunología , Proteínas de la Membrana/inmunología , Animales , Linfocitos T CD4-Positivos/citología , Linfocitos T CD8-positivos/citología , Quimiocina CX3CL1 , Quimiocinas CXC/análisis , Quimiocinas CXC/genética , Citometría de Flujo/métodos , Expresión Génica , Marcación de Gen , Intestino Delgado/citología , Intestino Delgado/inmunología , Listeria monocytogenes/inmunología , Proteínas de la Membrana/análisis , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , ARN/análisis , Tioglicolatos/administración & dosificación , Tioglicolatos/inmunologíaRESUMEN
Chemokine-directed migration of leukocyte subsets may contribute to the qualitative differences between systemic and mucosal immunity. Here, we demonstrate that in mice lacking the chemokine receptor CCR6, dendritic cells expressing CD11c and CD11b are absent from the subepithelial dome of Peyer's patches. These mice also have an impaired humoral immune response to orally administered antigen and to the enteropathic virus rotavirus. In addition, CCR6(-/-) mice have a 2-fold to 15-fold increase in cells of select T lymphocyte populations within the mucosa, including CD4+ and CD8+ alphabeta-TCR T cells. By contrast, systemic immune responses to subcutaneous antigens in CCR6(-/-) mice are normal. These findings demonstrate that CCR6 is a mucosa-specific regulator of humoral immunity and lymphocyte homeostasis in the intestinal mucosa.